EXTEDO Blog

Benefits of ePI for Patients

EMA Updates the eCTD v4 Timeline: What has Changed and What It Means for Regulatory Affairs

Why Can’t We View eCTD v4 Dossiers in a Browser? – Understanding the Technical Shift

Introduction of ePI – The Future of Medicines Information

Egyptian Drug Authority and EXTEDO Launch Phase II of Egypt’s Pharmaceutical Digital Transformation

EMA PMS Info Day 2026: The Future of Data-Driven Medicines Regulation in Europe

US FDA CDER Reveals Why Most eCTD v4 Submissions Fail (And How to Fix Them)

EXTEDO Experts sharing their Expertise - Where to Meet Them

eCTD v4: Understanding the New Language of Regulatory Submissions

Forward Compatibility in eCTD v4 – How to Carry Your Current eCTD v3 Application History Into the Future

Forward Compatibility in eCTD v4 – The Bridge to eCTD v4

Forward Compatibility in eCTD v4 – Your Organizational Roadmap and the EMA Pilot